Braden Michael Leonard Satsuma Pharmaceuticals, Inc. (STSA) insider trading activity

Braden Michael Leonard is > 10% Shareholder of Satsuma Pharmaceuticals, Inc.. Currently has a direct ownership of 150,000 shares of STSA, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2022, when has been sold 150,000 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $106,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K

0% 3M change

0% 12M change

Total Value Held $0

Braden Michael Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 21 2022	BUY Open market or private purchase	$106,500 $0.71 p/Share	150,000 Added 50.0%	150,000 Common Stock

Also insider at

GMTX

Gemini Therapeutics, Inc. Healthcare

> 10% Shareholder

IMRA

IMARA Inc. Healthcare

> 10% Shareholder

RVP

RETRACTABLE TECHNOLOGIES INC Healthcare

> 10% Shareholder

ASTC

ASTROTECH Corp Industrials

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

CYT

Cyteir Therapeutics, Inc. Healthcare

AVRO

AVROBIO, Inc. Healthcare

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

ACRS

Aclaris Therapeutics, Inc. Healthcare

ADVM

Adverum Biotechnologies, Inc. Healthcare

ANTX

AN2 Therapeutics, Inc. Healthcare

TLIS

Talis Biomedical Corp Healthcare

BML